Rouven Behnisch

Papers

Total Citations

118

H-Index

About

Rouven Behnisch is a leading surgical researcher whose work centers on advancing minimally invasive pancreatic surgery, with a particular focus on robotic techniques for complex procedures like pancreatoduodenectomy. His most impactful contribution is the landmark EUROPA trial (2024), a randomized controlled stage 2b study that directly compared robotic versus open partial pancreatoduodenectomy—a high-stakes operation for diseases of the pancreatic head. This trial, already cited over 118 times, provided critical evidence on the safety and efficacy of the robotic approach, challenging the gold standard of open surgery which carries around 40% morbidity. Behnisch’s work is pivotal in shaping modern surgical practice, offering patients potentially faster recovery with fewer complications. His research addresses a pressing clinical need, as robotic pancreatoduodenectomy is increasingly adopted worldwide despite limited randomized data. By generating high-quality evidence through rigorous trial design, Behnisch has established himself as a key figure in surgical oncology and health services research. His contributions not only inform clinical decision-making but also set the stage for future innovations in robotic-assisted surgery, making him a vital voice for students and researchers interested in the intersection of technology, patient outcomes, and surgical excellence.